Sentence examples for trials disclosure from inspiring English sources

Related sites PhRMA announcement of clinical trials policy National Institutes of Health-funded clinical trials registry Statement from medical journals on clinical trials disclosure.

"Group Weighs Plan for Full Drug-Trial Disclosure" (front page, June 15) reports on a new approach by medical journals to discourage pharmaceutical companies from withholding negative information from drug trials.

(See "Martha's Defense Gets Weird").. Jan . 29 , 2004U.S. District Judge Miriam Cedarbaum Miriam Cedarbaum delays Faneuil's testimony when it appears that prosecutors failed to comply with pre-trial disclosure obligations.

The following month, during parliamentary debates on major revisions to the Criminal Procedure Code, Lim suggested there was a need to improve pre-trial disclosure procedures and to ensure that victims of crimes received redress.

There was general agreement that, in addition to detailed consent procedures and clear methods for monitoring patients, acceptability would be enhanced if the trial were brief, and the post-trial disclosure of high quality: "I think the full disclosure of information at the end would go some way to persuade you in like your feelings about the wrongness of the deception.

Trial disclosures for new drugs remain below legal and ethics standards, with wide variation in practices among drugs and their sponsors.

From the journals' online author instructions we extracted information regarding endorsement of four domains of editorial policy: the Uniform Requirements for Manuscripts, trial registration, disclosure of conflicts of interest and five major reporting guidelines such as the CONSORT (Consolidated Standards of Reporting Trials) statement.

"I consider the judgement harsh given the surrounding context heard during proceedings and the clearly hostile feelings certain people within Glencore held for me being proven in pre-trial evidence disclosure".

This study cut-off date was chosen to provide at least 13 months for trial results disclosure post-FDA approval of a drug.

UMIN-CTR: UMIN000014712 (Date of ICMJE and WHO compliant trial information disclosure: 30 July 2014) Dementia is a topic of international concern, with rapid increase in the number of older adults with dementia in many countries.

"Sankofa" – is a two-arm randomized controlled clinical trial comparing disclosure intervention plus usual care (intervention arm) vs usual care (control arm) at Korle-Bu Teacontrolospitarm(KBTH; control and) and Komfo-Anokye Teachintervention (Karm; intervention arm).